Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Related press release
BNTC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the registration statements (No. 333-261874 and 333-253258) on Form S-8, registration statement (No. 333-253259) on Form S-3, and registration statement (No. 333-266417) on Form S-1 of Benitec Biopharma Inc. of our report (which expresses an unqualified opinion and includes an explanatory paragraph relating to Benitec Biopharma Inc.’s ability to continue as a going concern) dated September 2, 2022, relating to the consolidated financial statements of Benitec Biopharma Inc., appearing in this Annual Report on Form 10-K of Benitec Biopharma Inc. for the year ended June 30, 2022.
/s/ BAKER TILLY US, LLP |
Campbell, CA |
September 2, 2022 |